Recent News


Life Science Industry Veteran Stéphane Bancel Joins Flagship Ventures May 22, 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer May 22, 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer May 22, 2013
Frost & Sullivan Recognizes Selventa's Proprietary Systems Diagnostics Technology Platform May 13, 2013
Tetraphase Reports First Quarter 2013 Financial Results May 13, 2013
Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes May 10, 2013
Affinnova Wins SBANE Innovation Award May 10, 2013
BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer May 9, 2013
BG Medicine Reports 2013 First Quarter Financial Results May 9, 2013
T2 Biosystems Named 2013 SBANE New England Innovation Award Winner May 9, 2013
Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions May 8, 2013
Selventa Strengthens Intellectual Property for System Diagnostics (SysDx™) Approach to Personalized Medicine May 8, 2013
Eleven Biotherapeutics Presents Data on EBI-005, a Novel IL-1 Inhibitor Protein Therapeutic for Topical Treatment of Dry Eye Disease May 8, 2013
Receptos Announces Pricing of Initial Public Offering of Common Stock May 8, 2013
Concert Pharmaceuticals Announces Strategic Collaboration with Celgene Corporation to Develop Deuterium-Modified Compounds May 6, 2013
Henri A. Termeer Joins Moderna Therapeutics Board of Directors April 30, 2013
Tetraphase Presents Data at ECCMID Supporting Efficacy of Two Antibiotic Candidates Against Multi-Drug Resistant Infections April 29, 2013
Transmedics® Announces Interim Results From the International Inspire Pivotal Trial Using the OCS™ Lung System April 25, 2013
T2 Bio publishes data supporting diagnostic test T2Candida® in Science Translational Medicine April 24, 2013
Seegene and Selventa Form Strategic Collaboration to Develop Novel Molecular Diagnostics (MoDx) April 23, 2013
Joule Named 2013 New Energy Pioneer By Bloomberg April 23, 2013
Bind Therapeutics and AstraZeneca Announce Worldwide Development and Commercialization Agreement For Cancer Nanomedicine April 22, 2013
LS9 Expands Operations at Its Florida Demonstration Facility With Successful Customer Trial April 17, 2013
T2 Biosystems Announces Advances in Novel Hemostasis Direct Detection Program April 16, 2013
Joule Extends Solar CO2-Conversion Platform to Produce Renewable Gasoline and Jet Fuel April 15, 2013
Syros Pharmaceuticals Launches with $30 Million Series A Financing April 11, 2013
BG Medicine Welcomes CE Mark for Galectin-3 Test April 10, 2013
BIND Therapeutics Presents Positive Clinical Data at the AACR 2013 Annual Meeting for Lead Accurin Candidate, BIND-014, in Cancer Patients April 9, 2013
Foundation Medicine and Agios Announce Diagnostic Discovery Collaboration for IDH1 and IDH2 Cancer Metabolism Programs April 4, 2013
Agios Publishes Two Articles in Science Demonstrating the Effects of Mutant IDH1 and IDH2 Inhibitors in Primary Tumor Models April 4, 2013
Receptos Files Registration Statement for Proposed Initial Public Offering April 4, 2013
BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins™ April 3, 2013
T2 Biosystems Announces Issuance of Patent Covering T2Candida®Assay April 3, 2013
TARIS Secures $12.5 Million in Additional Financing; Initiates Phase 2 Trial of Lead Product Candidate April 2, 2013
Seventh Sense Biosystems Announces Initiation of Registration Trial for Painless TAP™ Blood Collection Device April 2, 2013
Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst April 1, 2013
T2 Biosystems Completes $40 Million Series E Financing to Support Clinical Programs and Commercialization of Sepsis Diagnostics March 28, 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536 March 26, 2013
AstraZeneca and Moderna Therapeutics announce exclusive agreement to develop pioneering messenger RNA Therapeutics™ in cardiometabolic diseases and cancer March 21, 2013
Tetraphase Pharmaceuticals Announces Pricing of Initial Public Offering March 20, 2013
Avedro Announces Preparation for Anticipated Hyperopic Lasik Xtra® US Clinical Trial March 13, 2013
BG Medicine Reports Fourth Quarter and Full Year 2012 Financial Results and Provides 2013 Outlook March 13, 2013
Receptos Licenses Anti-Interleukin-13 Antibody From AbbVie For Phase 2 Development In Orphan Disease March 13, 2013
Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals March 7, 2013
Acceleron Initiates Phase 2 Study of ACE-536 to Treat Patients with Beta-Thalassemia March 7, 2013
BG Medicine Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiology's (ACC) 62nd Annual Scientific Session & Expo March 6, 2013
Avedro Completes $43 Million Series D Financing March 5, 2013
David Edwards's WikiCell Makes Edible Food Packaging February 28, 2013
BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients February 27, 2013
The NEXT Next Big Thing February 27, 2013
Jazz Pharmaceuticals plc and Concert Pharmaceuticals Announce Worldwide Licensing Agreement to Develop and Commercialize Deuterium-Modified Sodium Oxybate February 26, 2013
Seahorse Bioscience XF Technology Yields Insights on Leukemia Stem Cell Metabolism and Potential New Leukemia Therapies February 22, 2013
Novomer Completes World’s First Large-Scale PPC Polyol Manufacturing Run February 20, 2013
Concert Pharmaceuticals Announces Completion of Enrollment in Phase 2 CTP-499 Clinical Trial for the Treatment of Diabetic Kidney Disease February 19, 2013
Eleven Biotherapeutics Publishes Data on EBI-005, a Novel IL-1 Inhibitor Protein for Topical Treatment of Dry Eye Disease February 19, 2013
Graham Cooper Appointed Chief Financial Officer of Receptos February 14, 2013
Ensemble Therapeutics Presents Data Demonstrating Unique Properties of Synthetic Macrocycles for Pursuing Challenging Targets February 13, 2013
Tetraphase Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering February 12, 2013
Concert Pharmaceuticals Announces Milestone Achievement in Avanir Pharmaceuticals Collaboration February 7, 2013
Acceleron Announces the Initiation of Phase 2 Clinical Trial of Dalantercept (ACE-041) in Patients with Ovarian Cancer February 5, 2013
Acceleron Initiates Phase 2 Study of Dalantercept (ACE-041) to Treat Patients with Metastatic Renal Cell Carcinoma February 5, 2013
T2 Biosystems Announces Patent Covering T2Hemostasis February 5, 2013
Tangent Medical Named Most Innovative Company for the 2013 Business Excellence Awards January 30, 2013
T2 Biosystems Announces Issuance of Patents Covering Components of the T2Dx Direct Detection Device January 29, 2013
Acceleron Initiates Phase 2 Study of ACE-536 to Treat Anemia in Patients with Myelodysplastic Syndromes January 29, 2013
LS9 Appoints Tjerk de Ruiter as President and Chief Executive Officer January 23, 2013
Selventa Developing Powerful New Class of Multi-omic Based Diagnostic Test for Autoimmune Disease and Cancer January 22, 2013
Moderna Appoints Divakar Ramakrishnan, Ph.D., As Senior Vice President Of Process Development, Manufacturing And Quality January 16, 2013
BIND and Amgen Sign Development & Commercialization Agreement for Kinase Inhibitor Nanomedicine January 8, 2013
BIND Granted 5 US Patents for Medicinal Nanoengineering® Platform & Lead Drug Candidate, BIND-014 January 8, 2013
Receptos Doses First Patient in Phase 2 Trial for RPC1063 in Ulcerative Colitis January 4, 2013
BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test January 2, 2013
Moderna Therapeutics Announces Appointment Of Stephen Hoge, MD As Senior Vice President Of Corporate Development And New Drug Concepts December 19, 2012
Blend Therapeutics Closes $16 Million in Series B Financing December 18, 2012
Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer December 18, 2012
BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe December 11, 2012
T2 Biosystems Presents Data on Rapid and Direct Hemostasis Monitoring at ASH 2012 December 10, 2012
Eleven Biotherapeutics Initiates Phase 1b Clinical Study of EBI-005, a Novel, Topically-delivered IL-1 Inhibitor Protein for the Treatment of Dry Eye Disease December 10, 2012
Moderna Announces $40 Million In Financing To Advance Development Of New Biotherapeutic Modality: Messenger RNA Therapeutics™ December 6, 2012
Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies for up to Three Allergy Indications Based on Selecta’s Synthetic Vaccine Particle Technology November 28, 2012
Governor Patrick Kicks Off Water Industry’s Trade Mission to Israel November 28, 2012
TransMedics, Inc. Secures $36 Million Round of Financing November 27, 2012
UCLA performs first 'breathing lung' transplant in United States November 26, 2012
bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays November 15, 2012
Affinnova Ranked Number 274 Fastest Growing Company in North America on Deloitte’s 2012 Technology Fast 500™ November 14, 2012
T2 Biosystems Announces Issuance of Patents Covering T2MR Direct Detection Technology November 14, 2012
BG Medicine Outlines New Commercial Strategy November 13, 2012
BG Medicine Reports Third Quarter 2012 Financial Results and Provides Business Update November 13, 2012
Joule, LS9, Mascoma, Novomer and Oasys named to AlwaysOn's 2012 GoingGreen Global 200 Top Private Companies November 13, 2012
Visterra Secures Financing from Gates Foundation and Omega to Close $26M Series A Financing November 9, 2012
BG Medicine Announces Data Analyses Presented at American Heart Association Meeting November 9, 2012
BG Medicine to Highlight Role of Galectin-3 Testing in Reducing Unplanned Hospital Readmissions at the 2012 American Heart Association (AHA) Scientific Sessions November 5, 2012
The Boston Globe Names Black Duck a Top Place To Work in 2012 November 5, 2012
Ensemble Therapeutics and Boehringer Ingelheim Initiate Collaboration to Discover Macrocycle Drug Candidates November 1, 2012
Avedro and EyeGate Pharma Enter Agreement for Corneal Cross-linking IP October 25, 2012
WikiCell Designs’ Edible Food and Beverage Packaging Receives Prestigious SIAL Global Food Industry Award October 22, 2012
LS9 Selected as a Top 10 Venture-Backed Green Company by The Wall Street Journal October 19, 2012
BG Medicine, Inc. Appoints Charles H. Abdalian, Jr. as Chief Financial Officer October 18, 2012
Joule, LS9 and Novomer Named to the Global Cleantech 100 2012 October 17, 2012
Keraflex® Keratoconus Treatment Study Begins in US October 11, 2012
The OCS™ Lung Initial European Clinical Experience Featured in The Lancet October 10, 2012
Life Sciences Venture Funding Drops October 5, 2012
LS9 Scales Up in Chemical Business As Biofuels Industry Re-Tools October 4, 2012
T2 Biosystems Named a "Fierce 15" Medical Device and Diagnostic Company of 2012 October 2, 2012
The Wall Street Journal Names Acceleron to "The Next Big Thing" List of Top 50 Start-Ups in the United States September 27, 2012
Flagship Ventures CEO keeps Merck aboard to inform biotech bets September 25, 2012
BIND Biosciences Appoints Industry Veteran Daniel Lynch as Chairman of the Board of Directors September 20, 2012
Black Duck Software Named to Software Magazine's 30th Annual Software 500 September 20, 2012
The Energy Of The Future Is Here: AeroShot Energy, New "Air-Based" Energy Product Launches Nationwide September 20, 2012
Joule Partners with Audi to Accelerate Development and Commercialization of Sustainable, Carbon-Neutral Fuels September 17, 2012
Tangent Medical Receives FDA Clearance for the NovaCath™ Secure IV Catheter System September 13, 2012
Visterra Signs Antibody Discovery Collaboration Deal With Pfizer September 11, 2012
Visterra Appoints Donna M. Ambrosino as Chief Medical Officer September 11, 2012
Joule Commissions First SunSprings™ Plant to Demonstrate Commercial Readiness September 11, 2012
Visterra Presents Preclinical Results that Shows 100% Prevention and Treatment of Influenza with VIS410, a Novel Engineered Human Antibody September 10, 2012
LS9 Announces Successful Start-up of Florida Demonstration Facility September 10, 2012
Startup WikiCell Designs Secures $10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners September 4, 2012
Joule Elects Caroline Dorsa to Board of Directors September 4, 2012
BG Medicine, Inc. Announces Publication of Important Galectin-3 Study Designed to Identify Adults in General Population at Risk for Heart Failure August 30, 2012
LS9 HIRES JONATHAN FOSTER AS CHIEF FINANCIAL OFFICER August 28, 2012
Top cities for technology start-ups August 23, 2012
Water Trumping Carbon Spreads $17 Billion Market August 23, 2012
Seahorse Bioscience Ranks No. 1600 on the Inc. 500\|5000 List of Fastest-Growing Private Companies in America for 2012 with Three-Year Sales Growth of 183% August 22, 2012
Swing Voters Prefer Women for VP Picks on Both 2012 Presidential Tickets August 22, 2012
LS9 Appoints Tjerk de Ruiter as Chairman of the Board August 15, 2012
Selventa CEO David de Graaf Named as one of PharmaVOICE Magazine's "100 Most Inspiring People in the Life Sciences" August 9, 2012
Quanterix Appoints Paul Chapman as President and Chief Executive Officer July 20, 2012
Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science July 12, 2012
AeroShot Energy Now Available Across New England July 10, 2012
Health and Sustainability Innovator Greg Horn Joins Flagship Ventures June 28, 2012
Health and Sustainability Innovator Greg Horn Joins Flagship Ventures June 28, 2012
Affinnova is Fastest-Rising Company on Honomichl Top 50 June 20, 2012
T2 Biosystems Presents Data on Novel Method for Endotoxin Detection at ASM 2012 June 18, 2012
BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Atherotech Diagnostics Lab June 18, 2012
Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing June 13, 2012
Avedro Announces CE Mark for its Newest Riboflavin Formulations June 12, 2012
LS9 Opens Florida Demonstration Facility for Renewable Products June 12, 2012
Ensemble Therapeutics and Genentech Initiate Collaboration to Discover Macrocyclic Drug Candidates May 29, 2012
Recent Flurry of New Life Science Funds Aim to Start Bridging the Valley of Death May 24, 2012